Hudson Bay Capital Management’s Eli Lilly LLY Stock Holding History

Hudson Bay Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.6M	Buy	67,004 +41,884	+167%	+$42.5M	0.21%	85
2025 Q4	$27M	Sell	25,120 -19,396	-44%	-$18.5M	0.09%	192
2025 Q3	$34M	Sell	44,516 -201,716	-82%	-$150M	0.11%	153
2025 Q2	$192M	Sell	246,232 -144,851	-37%	-$113M	0.65%	29
2025 Q1	$323M	Buy	391,083 +123,654	+46%	+$103M	1%	16
2024 Q4	$206M	Buy	267,429 +187,429	+234%	+$155M	0.73%	26
2024 Q3	$70.9M	Sell	80,000 -310,000	-79%	-$279M	0.29%	62
2024 Q2	$353M	Buy	+390,000	New	+$312M	1.66%	10
2024 Q1	–	Sell	-27,559	Closed	-$19.6M	–	820
2023 Q4	$16.1M	Buy	27,559 +7,559	+38%	+$4.41M	0.1%	126
2023 Q3	$10.7M	Sell	20,000 -5,500	-22%	-$2.83M	0.08%	152
2023 Q2	$12M	Buy	+25,500	New	+$10.7M	0.09%	152
2023 Q1	–	Sell	-200,000	Closed	-$73.2M	–	929
2022 Q4	$73.2M	Buy	+200,000	New	+$70.9M	0.75%	29
2021 Q2	–	Sell	-5,000	Closed	-$934K	–	987
2021 Q1	$934K	Buy	+5,000	New	+$978K	0.01%	692

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hudson Bay Capital Management's LLY Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Eli Lilly (LLY) stake by 167% in Q1 2026, buying an estimated $42.5M and bringing the position to 67,004 shares worth $61.6M. The position accounts for 0.21% of the portfolio, ranked #85.

Hudson Bay Capital Management first reported a position in LLY in Q1 2021 and has held it in 13 quarters since. The position peaked at $353M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Hudson Bay Capital Management held 67,004 shares of Eli Lilly worth $61.6M as of Q1 2026.
Hudson Bay Capital Management bought 41,884 Eli Lilly shares in Q1 2026, an estimated $42.5M.
Eli Lilly made up 0.21% of Hudson Bay Capital Management's portfolio in Q1 2026, its #85 holding.
Hudson Bay Capital Management first reported a position in Eli Lilly in Q1 2021 and has held it in 13 quarters since.
Hudson Bay Capital Management's Eli Lilly position peaked at $353M in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.